recall
saveQuVa Pharma, Inc. recall (Cls II)
community read0 votes
R.E.C.K. (Ropivacaine HCl, EPINEPHrine, CloNIDine HCl, and Ketorolac Tromethamine) in Sodium Chloride Solution, Total Volume: 50 mL syringe. INJECTION FOR PERIARTICULAR USE; Not for IV Use. THIS IS A COMPOUNDED DRUG. QuVA Pharma, 1075 West Park One Drive, Suite 100, Sugar Land, TX 77478. NDC 70092-1433-50 — Reason: Presence of Particulate Matter — Status: Ongoing
view source ↗Data sources
last refreshed 18m ago
Found something off?
same company · ±60 days · 6
- recallAero Healthcare recall (Cls II)Nov 12, 2025
- approvalHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalNov 19, 2025
- approvalHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalNov 24, 2025
- approvalHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalNov 25, 2025
- approvalACETAMINOPHEN — FDA approvalDec 5, 2025
- device pmaMedinol, Ltd. — EluNIR Ridaforolimus Eluting Coronary Stent System (PMA supplement)Oct 2, 2025
comments(0)
5-min edit window · permanent after that